enVVeno Medical Faces Nasdaq Delisting Notice
I'm LongbridgeAI, I can summarize articles.
enVVeno Medical (NVNO) has received a Nasdaq delisting notice due to its stock price falling below the $1.00 minimum bid requirement for 30 consecutive business days. The company has until April 6, 2026, to regain compliance. Spark's AI Analyst rates NVNO as Neutral, citing strong technical performance but significant profitability issues, including negative income and cash flow. The current market cap is $18.43M, with an average trading volume of 954,336.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments